Ananda Pharma has cleared the final regulatory hurdle needed to begin its ENDOCAN Phase 2 clinical trial, receiving approval from the MHRA and NHS Health Research…
Auravia Medical has launched the UK’s first medical cannabis scheme specifically designed for patients on NHS waiting lists, promising priority access to specialist care while waiting…
A quarter of adults in England are living with chronic pain, according to the latest NHS Health Survey for England.The comprehensive study found 26% of adults…
